Estrogen Receptor-negative Ductal Carcinoma In Situ (DCIS) of the Breast – an Institutional Review of Outcomes

EWA ZABROCKA; BERNARD NEWMAN; GABRIELLE LEVEY; KEITH SWEENEY; JAYMIE OENTORO; SAMUEL RYU; ALEXANDER STESSIN

doi:10.21873/anticanres.16591

Article Information

vol. 43 no. 9 4031-4036

DOI

https://doi.org/10.21873/anticanres.16591

PubMed

37648296

Published By

International Institute of Anticancer Research

Print ISSN

0250-7005

Online ISSN

1791-7530

History

Received June 13, 2023
Revision received July 17, 2023
Accepted July 21, 2023
Published online August 30, 2023.

Copyright © 2023 International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY-NC-ND) 4.0 international license (https://creativecommons.org/licenses/by-nc-nd/4.0).

Author Information

EWA ZABROCKA¹,
BERNARD NEWMAN²,
GABRIELLE LEVEY³,
KEITH SWEENEY⁴,
JAYMIE OENTORO⁵,
SAMUEL RYU¹ and
ALEXANDER STESSIN¹ ⇑

¹Department of Radiation Oncology, Stony Brook University, Stony Brook, NY, U.S.A.;
²Department of Family Medicine and Public Health, Division of Preventive Medicine, University of California San Diego, San Diego, CA, U.S.A.;
³University of Virginia School of Medicine, Charlottesville, VA, U.S.A.;
⁴Department of Pathology, University of Texas MD Anderson Cancer Center, Houston, TX, U.S.A.;
⁵Department of Pathology, Stony Brook University, Stony Brook, NY, U.S.A.

Correspondence to: Alexander Stessin, MD, Ph.D., Department of Radiation Oncology, Stony Brook University Hospital, 101 Nicolls Rd, Stony Brook, NY 11794, U.S.A. Tel: +1 6314442211, e-mail: alexander.stessin{at}stonybrookmedicine.edu

View Full Text